Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

9 results
Display

Synchronous Presentation of Ductal Carcinoma In Situ of the Breast with Follicular Lymphoma

Kim EY, Do SI, Park YL, Park CH

A synchronous incidence of breast cancer and follicular lymphoma (FL) is uncommon. The association between these two conditions could be explained by the antigenic stimulation of the adjacent carcinoma and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment with Cisplatin and Etoposide Chemotherapy in Patient with Metastatic Breast Cancer

Kim M, Lee JS

PURPOSE: Both the incidence of breast cancer as well as, the number of patients with metastatic breast cancer has increased. Taxane and anthracycline chemotherapy is known to be effective in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Retrospective Analysis of Idiopathic Granulomatous Mastitis: Its Diagnosis and Treatment

Jeon J, Lee K, Kim Y, Chun YS, Park HK

PURPOSE: Idiopathic granulomatous mastitis (IGM) is a rare disease characterized by noncaseating granulomatous inflammation of unknown origin. Because its clinical features are similar to those of other type of mastitis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Results of Absorbable Mesh Insertion and Patient Satisfaction in Breast-Conserving Surgery

Kwon EY, Yang YS, Choi EH, Han KD, Park YS, Kim CS

PURPOSE: Breast-conserving surgery (BCS) is a standard treatment for breast cancer. Occasionally, patients may be dissatisfied with the breast shape due to deformity after BCS. To ensure satisfactory cosmetic results,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Phosphorylated S6 Kinase-1 as Predictive Marker of Lapatinib Efficacy in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients

Ko EB, Seong MK, Choi HS, Park CS, Choi JH, Lee JK, Seol H, Kim HA, Noh WC

PURPOSE: The 40S ribosomal protein S6 kinase-1 (S6K1) is a crucial downstream effector of the PI3K/AKT/mTOR pathway. S6K1 overexpression is found in 10% to 30% of breast cancers and is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic Value of Estrogen and Progesterone Receptor Expression in Low Proliferative Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

Lee Y, Park I, Cho H, Yang K, Kim J, Park K, Gwak G

PURPOSE: Approximately two-thirds of breast cancer are estrogen-dependent cancers, which express estrogen receptor (ER)/progesterone receptor (PR). We investigated the prognostic value of ER/PR expression in human epidermal growth factor receptor 2...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Actual Conversion Rate from Total Mastectomy to Breast Conservation after Neoadjuvant Chemotherapy for Stages II–III Breast Cancer Patients

Mo H, Kim Y, Rhu J, Lee KH, Kim TY, Im SA, Lee ES, Lee HB, Moon HG, Noh DY, Han W

PURPOSE: Neoadjuvant chemotherapy (NCT) is a treatment modality that increases the breast-conserving rate in breast cancer. This prospective study was performed to evaluate the actual breast-conserving rate using NCT in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Utility of Shear Wave Elastography Patterns for Differentiating between Benign and Malignant Breast Lesions

Jung CS, Lee SH, Kim HY, Paik HJ, Nam KJ, Jo HJ, Jung YJ

PURPOSE: This retrospective study evaluated the utility of shear wave elastography (SWE), Tozaki's visual pattern classification, and conventional Breast Imaging Reporting and Data System (BI-RADS) classification for differentiating between benign...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Axillary Lymph Node to Primary Breast Tumor Standardized Uptake Value Ratio from FDG-PET/CT Imaging for Predicting the Necessity for Nodal Dissection in Primary Breast Tumors

Shin HK, Kim MK, Park SJ, Seok JW, Shin HC

PURPOSE: Accurate preoperative detection by radiologic assessment is necessary to specifically identify patients with at least three positive nodes, who can directly undergo axillary lymph node (ALN) dissection, and avoid...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr